Warning letter
California Pharmacy & Compounding Center: warning letter of Jun 17, 2015
FDA warning letter 452485 · Los Angeles District Office
Key facts
| Reference number | 452485 |
|---|---|
| Company | California Pharmacy & Compounding Center |
| Subject | Compounding Pharmacy/Adulteration/Misbranding |
| Issue date | Jun 17, 2015 |
| Posted date | Jul 28, 2015 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211.28(a), 201.115, 211.192, 211.42(c)(10)(iv), 211.42(c)(10)(vi), 211.113(b) |
| Inspection city | Newport Beach |
| Inspection ZIP | 92660 |
| Inspection start date | Oct 14, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: